» Articles » PMID: 29637495

High-throughput Genetic Screens Using CRISPR-Cas9 System

Overview
Journal Arch Pharm Res
Specialty Pharmacology
Date 2018 Apr 12
PMID 29637495
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

The CRISPR-Cas9 system is a powerful tool for genome engineering, and its programmability and simplicity have enabled various types of gene manipulation such as gene disruption and transcriptional and epigenetic perturbation. Particularly, CRISPR-based pooled libraries facilitate high-throughput screening for functional regulatory elements in the human genome. In this review, we describe recent advances in CRISPR-Cas9 technology and its use in high-throughput genetic screening. We also discuss its potential for drug target discovery and current challenges of this technique in biomedical research.

Citing Articles

Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria.

Ma J, Lu Z Microorganisms. 2025; 13(1).

PMID: 39858940 PMC: 11767912. DOI: 10.3390/microorganisms13010172.


Recent advances in CRISPR-based functional genomics for the study of disease-associated genetic variants.

Kim H, Kweon J, Kim Y Exp Mol Med. 2024; 56(4):861-869.

PMID: 38556550 PMC: 11058232. DOI: 10.1038/s12276-024-01212-3.


Research progress and application of the CRISPR/Cas9 gene-editing technology based on hepatocellular carcinoma.

Yu S, Zhao R, Zhang B, Lai C, Li L, Shen J Asian J Pharm Sci. 2023; 18(4):100828.

PMID: 37583709 PMC: 10424087. DOI: 10.1016/j.ajps.2023.100828.


Synthetic Vulnerabilities in the KRAS Pathway.

Roman M, Hwang E, Sweet-Cordero E Cancers (Basel). 2022; 14(12).

PMID: 35740503 PMC: 9221492. DOI: 10.3390/cancers14122837.


C/EBPδ-induced epigenetic changes control the dynamic gene transcription of and .

Jauch-Speer S, Herrera-Rivero M, Ludwig N, Veras De Carvalho B, Martens L, Wolf J Elife. 2022; 11.

PMID: 35543413 PMC: 9122501. DOI: 10.7554/eLife.75594.